English

24 MAY
SÃO PAULO – SP - BRAZIL
(NOVOTEL MORUMBI)

PARTICIPANTS PROFILE

Product categories

Branded generics: 37.5%

Biological products: 35.9%

Biosimilars: 26.6%

Hospital products: 31.3%

Innovative medicines: 51.6%

more info




Partnering Strategy/Interests

In-licensing: 45.3%

Out-licensing: 32.8%

Co-marketing: 28.1%

Co-promotion: 29.7%

Co-development: 39.1%

more info




Therapeutic areas

Cardiovascular: 45.3%

CNS: 54.7%

Infectious diseases: 34.4%

Pain: 46.9%

Respiratory: 31.3%

more info



PARTICIPANTS 2016

In-licensing: 45.3%

Out-licensing: 32.8%

Co-marketing: 28.1%

Co-promotion: 29.7%

Co-development: 39.1%

Technology transfer: 21.9%

Outsourcing: 12.5%

Others: 15.6%

partner